SPC315
Ozanimod eða lyfjafræðilega viðunandi salt þar af, sérstaklega ozanimodvetnisklóríð
Status:
VeittApplication date:
25.9.2020Application published:
15.10.2020Grant published:
15.3.2022
Max expiry date:
13.5.2034Medicine name:
ZeposiaMedicine for children:
No
Timeline
Today
25.9.2020Application
15.10.2020Publication
15.3.2022Registration
13.5.2034Expires
Marketing license
IS authorization number:
EU/1/20/1442/002-003 & EU/1/20/1442/001Date:
22.6.2020
Foreign authorization number:
EU/1/20/1442Date:
20.5.2020
Owner
Name:
The Scripps Research InstitutAddress:
10550 North Torrey Pines Road, La Jolla, CA US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2291080